KalVista Pharmaceuticals, Inc. (KALV) has 20 known insider and institutional holders on record. The largest holder is Venrock Healthcare Capital Partners III, L.P. with 5,129,340 shares. Other notable holders include Novo A/S and Novo Holdings A/S.
Over the last 12 months, insiders have made 84 transactions in KALV stock — 18 buys (valued at $3.5M) and 32 sells (valued at $1.92M). Insider selling has exceeded buying during this period.
KALV Insider Ownership
Top Holder
Venrock Healthcare Capital Partners III, L.P.
5,129,340 shares
Buys (12 mo)
18
$3.5M value
Sells (12 mo)
32
$1.92M value
12-Month Transaction Activity
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Venrock Healthcare Capital Partners Iii, L.p. |
10 Percent Owner |
5,129,340 |
2026-03-27 |
|
| 2 |
Novo A/s |
10 Percent Owner |
2,901,927 |
2016-11-30 |
|
| 3 |
Novo Holdings A/s |
10 Percent Owner |
1,762,000 |
2017-10-12 |
|
| 4 |
Venrock Healthcare Capital Partners Ii, L.p. |
10 Percent Owner |
1,544,112 |
2019-03-20 |
|
| 5 |
Ra Capital Management, Llc |
10 Percent Owner |
1,441,070 |
2017-10-16 |
|
| 6 |
Shah Rajeev M. |
10 Percent Owner |
1,441,070 |
2017-10-16 |
|
| 7 |
Renzi David |
President & CEO |
283,000 |
2016-01-05 |
|
| 8 |
Palleiko Benjamin L |
Chief Executive Officer |
125,001 |
2026-03-10 |
|
| 9 |
Maroney Marcee |
VP, Clinical Affairs |
100,000 |
2016-01-05 |
|
| 10 |
Gravett David M. |
VP, Research & Development |
100,000 |
2016-01-05 |
|
| 11 |
Audhya Paul K. |
Chief Medical Officer |
75,000 |
2026-02-24 |
|
| 12 |
Feener Edward P. |
Chief Scientific Officer |
72,858 |
2024-05-21 |
|
| 13 |
Ramiya Premchandran |
Vice President of Supply Chain |
60,586 |
2016-01-05 |
|
| 14 |
Saul David Joseph |
Director |
56,000 |
2016-02-02 |
|
| 15 |
Arif Bilal |
Chief Operations Officer |
49,000 |
2026-01-21 |
|
| 16 |
Svlsf Iv, Llc |
10 Percent Owner |
48,222 |
2019-04-10 |
|
| 17 |
Sweeny Nicole |
Chief Commercial Officer |
45,978 |
2026-02-24 |
|
| 18 |
Yea Christopher |
Chief Development Officer |
45,000 |
2026-02-24 |
|
| 19 |
Sensenig Bethany |
Director |
45,000 |
2025-10-02 |
|
| 20 |
Lewis Hayley |
See Remarks |
33,181 |
2015-08-05 |
|
Recent Transactions (last 12 months)
| Date |
Name |
Role |
Type |
Shares |
Price |
Value |
| 2026-03-26 |
Venrock Healthcare Capital Partners Iii, L.p. |
10 Percent Owner |
Informative Sell |
3,183 |
$19.12 |
$60.86K |
| 2026-03-25 |
Venrock Healthcare Capital Partners Iii, L.p. |
10 Percent Owner |
Informative Sell |
160 |
$17.53 |
$2.8K |
| 2026-03-09 |
Palleiko Benjamin L |
Chief Executive Officer |
Informative Sell |
6,693 |
$16.08 |
$107.63K |
| 2026-03-06 |
Palleiko Benjamin L |
Chief Executive Officer |
Option Exercise (Sell) |
15,625 |
- |
- |
| 2026-02-23 |
Audhya Paul K. |
Chief Medical Officer |
Informative Sell |
5,354 |
$15.57 |
$83.34K |
| 2026-02-22 |
Audhya Paul K. |
Chief Medical Officer |
Option Exercise (Sell) |
5,000 |
- |
- |
| 2026-02-21 |
Audhya Paul K. |
Chief Medical Officer |
Option Exercise (Sell) |
6,250 |
- |
- |
| 2026-02-23 |
Sweeny Nicole |
Chief Commercial Officer |
Informative Sell |
3,975 |
$15.57 |
$61.88K |
| 2026-02-22 |
Sweeny Nicole |
Chief Commercial Officer |
Option Exercise (Sell) |
5,000 |
- |
- |
| 2026-02-21 |
Sweeny Nicole |
Chief Commercial Officer |
Option Exercise |
6,250 |
- |
- |
| 2026-02-23 |
Piekos Brian |
Chief Financial Officer |
Informative Sell |
1,767 |
$15.57 |
$27.51K |
| 2026-02-21 |
Piekos Brian |
Chief Financial Officer |
Option Exercise |
5,000 |
- |
- |
| 2026-02-23 |
Yea Christopher |
Chief Development Officer |
Informative Sell |
4,347 |
$15.57 |
$67.67K |
| 2026-02-22 |
Yea Christopher |
Chief Development Officer |
Option Exercise (Sell) |
3,125 |
- |
- |
| 2026-02-21 |
Yea Christopher |
Chief Development Officer |
Option Exercise (Sell) |
3,750 |
- |
- |
| 2026-02-23 |
Palleiko Benjamin L |
Chief Executive Officer |
Informative Sell |
10,034 |
$15.57 |
$156.2K |
| 2026-02-21 |
Palleiko Benjamin L |
Chief Executive Officer |
Option Exercise (Sell) |
23,250 |
- |
- |
| 2026-02-18 |
Audhya Paul K. |
Chief Medical Officer |
Informative Sell |
1,163 |
$15.00 |
$17.45K |
| 2026-02-17 |
Audhya Paul K. |
Chief Medical Officer |
Option Exercise (Sell) |
2,419 |
- |
- |
| 2026-02-18 |
Yea Christopher |
Chief Development Officer |
Informative Sell |
1,109 |
$15.00 |
$16.64K |
| 2026-02-17 |
Yea Christopher |
Chief Development Officer |
Option Exercise (Sell) |
1,774 |
- |
- |
| 2026-02-18 |
Palleiko Benjamin L |
Chief Executive Officer |
Informative Sell |
1,038 |
$15.00 |
$15.57K |
| 2026-02-17 |
Palleiko Benjamin L |
Chief Executive Officer |
Option Exercise (Sell) |
2,419 |
- |
- |
| 2026-02-12 |
Palleiko Benjamin L |
Chief Executive Officer |
Informative Sell |
3,354 |
$15.70 |
$52.66K |
| 2026-02-11 |
Palleiko Benjamin L |
Chief Executive Officer |
Option Exercise (Sell) |
7,120 |
- |
- |
